EcoR1 Capital, LLC's Form 4 filing
Corvus Pharmaceuticals, Inc. (CRVS) · filed Oct 1, 2021
- Accession no.
- 0001567619-21-017771
- Filed
- Oct 1, 2021
- Trade date
- Sep 30-Oct 1, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $25.0M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | Common Stock | SSaleDisposed | −3,000,000 | $5.04 | −$15,120,000 | 2,081,077 | Indirect | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −2,000,000 | $4.96 | −$9,920,000 | 81,077 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.